NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Krispy Kreme, Inc. (NASDAQ: DNUT).Shareholders who purchased shares of DNUT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/krispy-kreme-inc-loss-submission-form/?id=156030&from=4CLASS PERIOD: March 26, 2024 to ...

NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF).Shareholders who purchased shares of WOOF during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/petco-loss-submission-form/?id=156043&from=4CLASS PERIOD: January ...

NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN).Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=156033&from=4CLASS PERIOD: October 31, 2024 to April 30, 20 ...

NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD).Shareholders who purchased shares of DDD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=156039&from=4CLASS PERIOD: August 13, ...

NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT).Shareholders who purchased shares of RCKT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/rocket-pharmaceuticals-inc-loss-submission-form/?id=156038&from=4CLASS PERIO ...

NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DoubleVerify Holdings, Inc. (NYSE: DV).Shareholders who purchased shares of DV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/doubleverify-holdings-inc-loss-submission-form-2/?id=156031&from=4CLASS PERIOD: Nov ...

NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Reddit, Inc. (NYSE: RDDT).Shareholders who purchased shares of RDDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/reddit-inc-loss-submission-form/?id=156040&from=4CLASS PERIOD: October 29, 2024 to May 20, 202 ...

Core Viewpoint - ClaimsFiler informs investors about the deadline to file lead plaintiff applications in securities class action lawsuits against Organon & Co. for the Class Period from October 31, 2024, to April 30, 2025 [1] Group 1: Lawsuit Details - Organon and certain executives are accused of failing to disclose material information during the Class Period, violating federal securities laws [3] - The first-filed case is Hauser v. Organon & Co., et al., and a subsequent case, Lerner v. Organon & Co., et al., expanded the class period [5] Group 2: Financial Impact - On March 10, 2025, Organon announced a significant reduction in its dividend payout from $0.28 to $0.02, which contradicted previous assurances to investors [4] - Following the dividend announcement, Organon's share price dropped over 27%, from $12.93 on April 30, 2025, to $9.45 on May 1, 2025 [4] Group 3: Investor Support - ClaimsFiler provides resources for investors to recover funds from securities class action settlements, including free registration for information access and case evaluations [6]

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF) investors of a class action representing investors that bought securities between January 14, 2021 and June 5, 2025, inclusive (the "Class Period"). Petco investors have until August 29, 2025 to file a lead plaintiff motion. Investors are encouraged to contact att ...

Core Viewpoint - A class action lawsuit has been filed against iRobot Corporation, alleging that the company misrepresented the effectiveness of its restructuring plan following a failed merger with Amazon, leading to significant investor losses [3][4]. Group 1: Lawsuit Details - The class action represents investors who purchased iRobot securities between January 29, 2024, and March 11, 2025, with a deadline of September 5, 2025, to file a lead plaintiff motion [1]. - The lawsuit claims that iRobot overstated the stability provided by its restructuring plan, raising doubts about its long-term viability as an independent company [3]. Group 2: Financial Performance - iRobot reported a loss of $2.06 per share for Q4 and the full year 2024, with revenue of $172 million, marking a 44% decline from the previous year [4]. - The company's statement indicated "substantial doubt" about its ability to continue as a going concern for at least the next 12 months, which led to a stock price drop of over 51% following the announcement [4].